Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies
The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and vaccination. Because the androgen-responsive serine protease TMPRSS2 is involved in cleaving the SARS-CoV-2 spike protein allowing the virus to enter the...
Главные авторы: | Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, Fatima O. Alsamani |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Elsevier
2022-01-01
|
Серии: | Informatics in Medicine Unlocked |
Предметы: | |
Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2352914822000247 |
Схожие документы
-
Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies
по: Abdulrahim A. Alzain, PhD, и др.
Опубликовано: (2021-01-01) -
Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies
по: Fatima A. Elbadwi, и др.
Опубликовано: (2021-01-01) -
Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
по: Mushtaq Hussain, и др.
Опубликовано: (2020-09-01) -
Identification of potent TMPRSS4 inhibitors through structural modeling and molecular dynamics simulations
по: Ismail Hdoufane, и др.
Опубликовано: (2025-01-01) -
Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19
по: Sergio Vazquez-Rodriguez, и др.
Опубликовано: (2023-01-01)